Lilly’s stock tumbled as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
www.marketwatch.com
#Eli #Lillys #weightloss #pill #didnt #work #stock #plunging
Related Posts
Exclusive-China’s central bank asks financial institutions about dollar weakness, sources say
(Reuters) -China’s central bank has asked some financial institutions about their views on recent U.S. dollar weakness, people with knowledge…
Comfort food, fast food brand closing dozens of restaurants
Getting smaller isn’t always a bad thing. Even really successful brands need to close stores in some situations due to…

Gold Rises Above $3,700 for First Time on Fed Rate Cut Optimism
(Bloomberg) — Gold hit a fresh record as investors bet on a US Federal Reserve rate cut this week and…

